Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05295823 · ClinicalTrials.gov registry record · NA

Patient Self Measurement of Post-Void Residual Bladder Volume (PVR) Using Ultrasound

A NA study of Voiding Dysfunction and Voiding Disorders, sponsored by Yale University.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT05295823 is a NA study of Voiding Dysfunction and Voiding Disorders that has completed, run by Yale University. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05295823, a NA study of Voiding Dysfunction and Voiding Disorders, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This study would be the first to demonstrate feasibility, accuracy, reliability, clinical care impact, and patient satisfaction with remote monitoring of post-void residual bladder volume (PVR) using the Butterfly portable ultrasound device in patients with obstructive voiding dysfunction.

Interventions

  • DEVICE Butterfly portable ultrasound device with bladder ultrasound images
  • DEVICE Butterfly portable ultrasound device with abstract bladder images

Study Locations (1)

Connecticut

  • Yale New Haven Hospital - New Haven

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2022-04-27
Est. Completion 2022-06-03
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT05295823

The ClinicalTrials.gov registry entry for NCT05295823 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Voiding Dysfunction appearing as the primary indexed condition, and to 2 interventions - of which Butterfly portable ultrasound device with bladder ultrasound images is the first listed.

NCT05295823 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT05295823 about?

NCT05295823 is a clinical study titled "Patient Self Measurement of Post-Void Residual Bladder Volume (PVR) Using Ultrasound". This study would be the first to demonstrate feasibility, accuracy, reliability, clinical care impact, and patient satisfaction with remote monitoring of post-void residual bladder volume (PVR) using the Butterfly portable ultrasound device in patients with obstructive voiding dysfunction.

What is the current status of trial NCT05295823?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2022-04-27. Estimated completion is 2022-06-03.

What conditions does trial NCT05295823 study?

This clinical trial studies the following conditions: Voiding Dysfunction, Voiding Disorders.

What interventions are being tested in trial NCT05295823?

The interventions under investigation include: Butterfly portable ultrasound device with bladder ultrasound images (DEVICE), Butterfly portable ultrasound device with abstract bladder images (DEVICE).

Who is sponsoring clinical trial NCT05295823?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05295823 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Voiding Dysfunction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.